PRKD1 and prostate carcinoma: While epigenetic inactivation of Prkd1 by hypermethylation of the gene promoter has been described in breast and gastric cancer [31–33], repression of Prkd1 expression by nuclear β-catenin has been observed in colon and prostate cancer [34, 35].